S1 Biopharma is developing first-in-class drugs for the treatment of sexual dysfunction and hypoactive sexual desire disorder (HSDD) in both women and men. The company’s non-hormonal therapies work uniquely by restoring the natural balance of neurotransmitters in the brain.

Pharmaceutical

S1 Biopharma

S1 Biopharma's headquarters in New York, NY, United States

Nicolas G. Sitchon

John F. Kaufmann

Cindy M. Meston

Robert Taylor Segraves

Gregg A. Lapointe

Anita H. Clayton

Leonard R. Derogatis

Jane H. Hollingsworth

Molly A. Katz

Description

People (1)

Nicolas G. Sitchon

Jobs